News Releases

May 4, 2021

Mutations in breast cancer susceptibility genes are known to increase the risk of inheriting breast cancer. Genetic testing enables persons to determine if they carry that mutation and are at a higher risk of developing cancer. Understanding that risk may help patients make treatment decisions...

April 28, 2021

Adult vaccination rates in the US are generally low and fall short of public health goals. Given the human and economic burden of vaccine-preventable disease, understanding the factors behind these low coverage rates is critical to improving participation. 

April 6, 2021

Many patients with Parkinson's disease experience periods during the day of "OFF" episodes, or worsening of symptoms.

March 23, 2021

What do rapidly changing technologies mean to the collection of stated-preference studies – studies that ask individuals what they value in their health and health care?

March 12, 2021

Insights from our experiences developing medical product dossiers, with key considerations for manufacturers planning to develop early dossiers for their products.

February 10, 2021

For the fifth straight year, Forbes has included RTI in its list of America’s Best Midsize Employers

February 1, 2021

MINERVA project (Metadata for data discoverability and study replicability in observational studies) is launched

January 28, 2021

"I am honored to serve on the ENCePP Steering Committee on behalf of research centers in Europe."

January 25, 2021

The US Food and Drug Administration (FDA) is no longer requiring a black box warning on the label for the drug FORTEO® (teriparatide) and has released the drug’s sponsor from its post-market commitments.  These moves were based on results from 18 years of epidemiologic research conducted by...

January 22, 2021

Please join Xabier Garcia de Albeniz for this recorded 30-minute case-study workshop on the use of causal inference methods for real-world evidence.

January 15, 2021

Launch of the SIGMA Consortium heralds a new era of collaboration to better understand safety and effectiveness of medical interventions.

January 11, 2021

In 2019, the US Department of Health and Human Services (HHS) announced the “Ending the HIV Epidemic: A Plan for America” initiative. As part of that initiative, CDC, RTI Health Solutions (RTI-HS), and RTI International researchers performed a study on allocating funds for HIV prevention to...

November 20, 2020

HTAi symposium highlights - value assessment in Alzheimer's disease research should incorporate the breadth of relevant outcomes

November 20, 2020

Antibiotics have played a significant role in expanding life expectancy over the last 100 years. However, bacteria have evolved and developed the genetic machinery to adapt and resist antimicrobials, threatening to make antibiotics ineffective – known as antimicrobial resistance (AMR). The...

November 17, 2020

it also explains Markov and Budget Impact Analysis modeling and discusses the advantages and disadvantages of using retrospective databases and real-world data

October 27, 2020

RTI Health Solutions (RTI-HS) is pleased to announce that we are a certified facilitator for the Medtech Early Technical Assessment (META) tool developed by the National Institute for Health and Care Excellence (NICE). META is an online platform designed to provide a budget-friendly value...

October 27, 2020

A first-time study determined that just 30.6% of US 17-year-olds had received all vaccines

October 6, 2020

RTI Health Solutions is pleased to announce that Brett Hauber, PhD, Senior Economist and VP, Health Preference Assessment, has been appointed as Senior Fellow in the RTI Fellow Program.

September 30, 2020

We're excited to reach this milestone in our journey

September 11, 2020

RTI Health Solutions (RTI-HS) is proud to announce that two of our researchers have been awarded fellowship status by the International Society for Pharmacoepidemiology (ISPE) Board of Directors. Both Alicia Gilsenan, PhD, RPh, and Andrea Margulis, MD, ScD, will be acknowledged as new FISPE...

September 3, 2020

On August 31, 2020, the FDA released its draft guidance titled “Principles for Selecting, Developing, Modifying, and Adapting Patient-Reported Outcome Instruments for Use in Medical Device Evaluation.” 

July 20, 2020

The Author Awards Program, now in its 17th year, was established by the RTI Fellows as a way to recognize staff members

June 29, 2020

In advance of an approved COVID-19 vaccine, the European Medicines Agency (EMA) has commissioned research to monitor any vaccine that is approved for its safety and effectiveness in clinical practice.

May 27, 2020

Multiple myeloma (MM) is a type of blood cancer that occurs in our body’s plasma cells. Rapidly reproducing, cancerous cells collect in bone marrow and crowd out healthy cells. Myeloma cells produce antibodies that, instead of fighting off infection, cause problems such as kidney and bone damage...